Jones Financial Companies
PPBT

Jones Financial Companies’s Purple Biotech PPBT Stock Holding History

Jones Financial Companies’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20 Hold
5
– – ﹤0.01% 4690
2025
Q4 		$33 Buy
+5
New +$36 ﹤0.01% 4354

Other funds holding PPBT

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jones Financial Companies's PPBT Position: Q1 2026 in Review

Jones Financial Companies held its Purple Biotech (PPBT) position steady in Q1 2026 at 5 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #4690.

Jones Financial Companies first reported a position in PPBT in Q4 2025 and has held it in 2 quarters since. The position peaked at $33 in Q4 2025. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

  • Jones Financial Companies held 5 shares of Purple Biotech worth $20 as of Q1 2026.
  • Jones Financial Companies left its Purple Biotech share count unchanged in Q1 2026.
  • Purple Biotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4690 holding.
  • Jones Financial Companies first reported a position in Purple Biotech in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's Purple Biotech position peaked at $33 in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.